Steven Bellon

2023

In 2023, Steven Bellon earned a total compensation of $1.2M as Chief Scientific Officer at Foghorn Therapeutics, a 45% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$124,600
Option Awards$614,894
Salary$445,000
Other$3,000
Total$1,187,494

Bellon received $614.9K in option awards, accounting for 52% of the total pay in 2023.

Bellon also received $124.6K in non-equity incentive plan, $445K in salary and $3K in other compensation.

Rankings

In 2023, Steven Bellon's compensation ranked 997th out of 2,816 executives tracked by ExecPay. In other words, Bellon earned more than 64.6% of executives.

ClassificationRankingPercentile
All
997
out of 2,816
65th
Division
Manufacturing
600
out of 1,551
61st
Major group
Chemicals And Allied Products
414
out of 877
53rd
Industry group
Drugs
403
out of 840
52nd
Industry
Pharmaceutical Preparations
276
out of 605
54th
Source: SEC filing on May 3, 2024.

Bellon's colleagues

We found two more compensation records of executives who worked with Steven Bellon at Foghorn Therapeutics in 2023.

2023

Adrian Gottschalk

Foghorn Therapeutics

Chief Executive Officer

2023

Alfonso Quintás-Cardama

Foghorn Therapeutics

Chief Medical Officer

News

In-depth

You may also like